Non-Rodent Genetic Animal Models for Studying Tauopathy: Review of Drosophila , Zebrafish, and C. elegans Models

• Published in: International journal of molecular sciences Vol. 22; no. 16; p. 8465
• Main Authors: Giong, Hoi-Khoanh, Subramanian, Manivannan, Yu, Kweon, Lee, Jeong-Soo
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 06.08.2021; MDPI
• Subjects: advantages; Alzheimer's disease; Animal models; Animals; Brain; C. elegans; Caenorhabditis elegans - genetics; Caenorhabditis elegans - physiology; Degeneration; Dementia; Disease Models, Animal; Drosophila; Drosophila - genetics; Drosophila - physiology; Frontotemporal dementia; Fruit flies; High-throughput screening; Humans; Insects; Kinases; Neurodegeneration; Neuroimaging; Pathology; pathophysiology; Phenotypes; Phosphatase; Phosphorylation; Proteins; Review; Tau protein; tau Proteins - genetics; Tauopathies - genetics; Tauopathies - physiopathology; tauopathy; Zebrafish; Zebrafish - genetics; Zebrafish - physiology; C. elegans; tauopathy; advantages; Drosophila; pathophysiology; zebrafish; limitations
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms22168465

Tauopathy refers to a group of progressive neurodegenerative diseases, including frontotemporal lobar degeneration and Alzheimer's disease, which correlate with the malfunction of microtubule-associated protein Tau (MAPT) due to abnormal hyperphosphorylation, leading to the formation of intracellular aggregates in the brain. Despite extensive efforts to understand tauopathy and develop an efficient therapy, our knowledge is still far from complete. To find a solution for this group of devastating diseases, several animal models that mimic diverse disease phenotypes of tauopathy have been developed. Rodents are the dominating tauopathy models because of their similarity to humans and established disease lines, as well as experimental approaches. However, powerful genetic animal models using , zebrafish, and have also been developed for modeling tauopathy and have contributed to understanding the pathophysiology of tauopathy. The success of these models stems from the short lifespans, versatile genetic tools, real-time in-vivo imaging, low maintenance costs, and the capability for high-throughput screening. In this review, we summarize the main findings on mechanisms of tauopathy and discuss the current tauopathy models of these non-rodent genetic animals, highlighting their key advantages and limitations in tauopathy research.